|
ALDH9A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
2.56989984848133E-11 |
| Normal-vs-Stage3 |
1.25679999740669E-09 |
| Normal-vs-Stage4 |
3.08959968720046E-10 |
| Stage1-vs-Stage2 |
6.667800E-01 |
| Stage1-vs-Stage3 |
1.411240E-01 |
| Stage1-vs-Stage4 |
9.683200E-01 |
| Stage2-vs-Stage3 |
4.114200E-01 |
| Stage2-vs-Stage4 |
6.636800E-01 |
| Stage3-vs-Stage4 |
3.208400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.3988810110277E-14 |
| Normal-vs-Asian |
4.16149999999949E-05 |
| Caucasian-vs-AfricanAmerican |
3.921200E-01 |
| Caucasian-vs-Asian |
7.254600E-01 |
| AfricanAmerican-vs-Asian |
5.679600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.96098692839541E-12 |
| Normal-vs-Female |
1.72339920112563E-12 |
| Male-vs-Female |
8.163100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.54150034351142E-11 |
| Normal-vs-Extreme_Weight |
5.20694598549198E-14 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
7.26370000037058E-07 |
| Normal_Weight-vs-Extreme_Weight |
6.130300E-02 |
| Normal_Weight-vs-Obese |
5.691000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.231800E-01 |
| Extreme_Weight-vs-Obese |
7.275800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.801800E-01 |
| Obese-vs-Extreme_Obese |
9.404200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.65183447317941E-13 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.49280000000451E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.355790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.650000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.439440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.412600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.499800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.091400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.69331215715829E-12 |
| Normal-VS-Type2 PRCC |
1.09090003697077E-09 |
| Normal-VS-KIRP CIMP |
2.85069967631557E-10 |
| Normal-VS-Unclassified PRCC |
9.3958174574027E-13 |
| Type1 PRCC-VS-Type2 PRCC |
5.48910000008895E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.601000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.927800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.920000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.956700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.317200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88737914186277E-15 |
| Normal-vs-N1 |
3.17589999854206E-08 |
| Normal-vs-N2 |
3.181800E-04 |
| N0-vs-N1 |
1.981230E-01 |
| N0-vs-N2 |
7.091600E-01 |
| N1-vs-N2 |
4.016800E-01 |
|
|
